SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research.

中文翻译：

---

癌症患者对 COVID-19 疫苗的免疫反应：有希望的结果和注意事项

SARS-CoV-2 疫苗可有效预防 COVID-19。癌症患者患严重 COVID-19 的风险很高，因此可以适当优先接种疫苗。本期《Cancer Cell》中的几项研究增加了我们对癌症患者接种疫苗免疫反应异质性的认识，并确定了未来研究的重要领域。